期刊文献+

人参皂甙Rg1通过P38信号通路影响帕金森病MPTP模型小鼠黑质COX-2的表达 被引量:17

Ginsenoside Rg1 modulates COX-2 expression in the substantia nigra of mice with MPTP-induced Parkinson disease through the P38 signaling pathway
下载PDF
导出
摘要 目的研究P38信号通路在1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)所致小鼠帕金森病(PD)模型中对环氧合酶-2(COX-2)的表达调控作用,以探讨导致多巴胺(DA)能神经元变性失活的可能机制,以及人参皂甙Rg1对P38信号通路的影响和对多巴胺神经元的保护作用。方法采用MPTP制备亚急性PD小鼠模型,用免疫组织化学和免疫蛋白印记法,观察小鼠黑质酪氨酸羟化酶(TH),COX-2,前列腺素E2(PGE2)以及磷酸化P38(p-P38)的表达变化;并观察给予人参皂甙Rg1对上述变化的影响。结果与对照组小鼠相比,模型组小鼠出现典型PD症状,在MPTP第3次注射后6 h,黑质区p-P38,COX-2,PGE2阳性细胞显著增加(P<0.01)。在MPTP第5次注射后24 h,黑质区TH阳性神经元显著丢失60%(P<0.01);经人参皂甙Rg1处理后,模型小鼠PD症状减轻,与模型组比较,在MPTP第3次注射后6 h,黑质区p-P38,COX-2,PGE2阳性细胞明显减少(P<0.01),在MPTP第5次注射后24 h,TH阳性细胞数较对照组仅下降30%。结论P38通路在亚急性PD模型早期对黑质COX-2表达可能起重要调控作用;人参皂甙Rg1可影响P38信号通路及C0X-2的表达而对小鼠多巴胺神经元起到一定保护作用。 Objective To investigatc the role of P38 signaling pathway in modulating the expression of cyclooxygenase-2 (COX-2) in the substantia nigra (SN) of mice with 1-mcthyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced Parkinson disease (PD), and explore the possible mechanism of the dopaminergic (DA) neuron death in PD and the effects ofginsenoside Rgl on the P38 signaling pathway and DA neurons. Methods C57BL6 mice were treated with MPTP to produce the subacute PD model, and the behavioral changes were observed. Immunohistochemistry and Western blotting for tyrosine hydroxylase (TH), COX-2, prostaglandin E2 (PGE2) and phosphorylated P38 (p-P38) were used to observe the changes of positive cell number in the midbrain after treatment with ginsenoside Rgl. Results Compared with the control mice, the mice with PD presented with typical symptoms of PD. The number of p-P38-, COX-2-, and PGE2-positive cells significantly increased in the SN area 6 h after the 3rd injection of 30 mg/kg MPTP (P〈0.01). The number of TH-positive neurons in the PD model group was substantially reduced by about 60% (P〈0.01) in 24 h after the 5th injection of MPTP. In mice with ginsenoside Rgl treatment, the number of p-P38-, COX-2-, and PGE2-positive cells was reduced obviously 6 h after the 3rd injection of MPTP as compared with that in the model group (P〈0.01). The number of TH-positive neurons in the SN was decreased by only 30% (P〈0.01 vs control group) 24h after the 5th injection of MPTP. Conclusion P38 signaling pathway may play an important role in modulating COX-2 expression in the SN in the early stage of MPTP-induced subacute PD, and ginsenoside Rgl may act on the P38 signaling pathway to protect the DA neurons in PD.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2008年第9期1594-1598,共5页 Journal of Southern Medical University
基金 河北省自然科学基金(C2004000689) 河北省博士基金(05547008D-4) 河北省科学技术与社会发展计划项目(04276135)
关键词 帕金森病 炎症 环氧合酶-2 前列腺素E2 磷酸化P38 人参皂甙RG1 Parkinson disease neuroinflammation cyclooxygenase-2 prostaglandin E2 phosphorylated P38 ginsenoside Rgl
  • 相关文献

参考文献12

  • 1Hald A, Lotharius J. Oxidative stress and inflammation in Parkinson's disease: Isthere a causallink [J]? Exp Neurol, 2005, 193 (2): 279-90.
  • 2师亮,张宇新,张作凤,陈浩.COX-2对帕金森病小鼠黑质内多巴胺能神经元的毒性作用[J].第四军医大学学报,2006,27(18):1661-1664. 被引量:9
  • 3Roux PP, Blenis John. ERK and p38 MAPK-Activated Protein Kinases: a family protein kinases with diverse biological functions [J]. Microbio Mole Biol Rev, 2004, 68(2): 320-44.
  • 4黄翠萍,张珍祥,徐永健.P38蛋白激酶对肺泡巨噬细胞环氧合酶-2 mRNA表达的影响[J].华中科技大学学报(医学版),2003,32(1):39-42. 被引量:3
  • 5黎钢,马嵘,孙圣刚,童萼塘.p38 MAPK信号通路在小胶质细胞激活介导多巴胺能神经元变性中的作用研究[J].脑与神经疾病杂志,2006,14(2):105-107. 被引量:2
  • 6Smeyne RJ, Jackson-Lewis V. The MPTP model of Parkinson's diseaseIJ ]. Brain Res Mol Brain Res, 2005, 134 (1): 57-66.
  • 7Marchetti B, Abbracchio MP. To be or not to be (inflamed)-is that the question in anti-inflammatory drug therapy ofneurodegenemtive disorders [J]. Trends Pharmacol Sci, 2005, 26 (10): 517-25.
  • 8Minghetti L. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain disease[J]. Neuropathol Exp Neurol, 2004, 63 (9):901-10.
  • 9Wang T, Pei Z, Zhang W, et al. MPP+-induced COX-2 activation and subsequent dopaminergic neurodegeneration [J]. FASEB J, 2005, 19(9): 1134-6.
  • 10Degousee N, Martindale J, Stefanski E, et al. MAP kinase kinase 6-p38 MAP kinase signaling cascade regulates cyclooxygenase-2 expression in cardiac myocytes in vitro and in vivo[J]. Circ Res, 2003, 92( 1 ): 757-64.

二级参考文献36

  • 1Sheer TB,Betarbet R,Kim JH,et al.Selective microglia activation in the rat rotenone model of Parkinson's disease.Neurosci Lett,2003,341:87~90
  • 2Kim WG,Mohney RP,Wilson B,et al.Regional difference in susceptibility to Lipopolysaccharide-induced neurotoxicity in the rat brain:role of microglia.J Neuorsci,2000,20:6309~6316
  • 3Bhat NR,Zhang P,Lee JC,et al.Extracellular signal-regulatedkinase and p38 subgroups of mitogen-activated protein kinases regulateinducible nitric oxide synthase and tumor necrosis factor gene expressionin endotoxin-stimulated primary glial cultures.J Neurosci,1998,18:1633~1641
  • 4Tikka T,Fiebich BL,Goldsteins G,et al.Minocycline,a tetracycline derivative,is neuroprotective against excitotoxicityby inhibiting activation and proliferation of microglia.J Neurosci,2001,21:2580~2588
  • 5Choi SH,Joe EH,Kim SU,et al.Thrombin-induced microglia activation products degeneration of nigral dopaminergic neurons in vivo.J Neurosci,2003,23:5877~5886
  • 6Wang MJ,Lin WW,Chen HL,et al.Silymarin protects dopaminergic neurons against lipopolysaccharide-induced neurotoxicity by inhibiting microglia activation.Eur J Neurosci,2002,16:2103~2112
  • 7Jeohn GH,Cooper CL,Wilson B,et al.p38 MAP kinase is involved in Lipopolysaccharide-induced dopaminergic neuronal cell death in rat mesencephalic neuron-glia cultures.Ann.N.Y.Acad.Sci,2002,962:332~346
  • 8Shibata H,Kasuki H,Nishiwaki M,et al.Lipopolysaccharide-induced dopaminergic cell death in rat midbrain slice cultures:role of inducible nitric oxide synthase and protection by indomethacin.J Neurochem,2003,86:1201~1212
  • 9Mirza BH,Thomesn HP,Moos T.The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease.Neuroscience,2000,95:425~432
  • 10Wu DC,Jackson V,Vila M,et al.Blockade of microglia activation is neuroprotective in the MPTP mouse model of Parkinson disease.J Neurosci,2002,22:1763~1771

共引文献21

同被引文献293

引证文献17

二级引证文献153

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部